Chronic Inflammatory Diseases at Secondary Sites Ensuing Urogenital or Pulmonary Chlamydia Infections
Open Access
- 17 January 2020
- journal article
- review article
- Published by MDPI AG in Microorganisms
- Vol. 8 (1) , 127
Abstract
Chlamydia trachomatis and C. pneumoniae are members of the Chlamydiaceae family of obligate intracellular bacteria. The former causes diseases predominantly at the mucosal epithelial layer of the urogenital or eye, leading to pelvic inflammatory diseases or blindness; while the latter is a major causative agent for pulmonary infection. On top of these well-described diseases at the respective primary infection sites, Chlamydia are notoriously known to migrate and cause pathologies at remote sites of a host. One such example is the sexually acquired reactive arthritis that often occurs at few weeks after genital C. trachomatis infection. C. pneumoniae, on the other hand, has been implicated in an extensive list of chronic inflammatory diseases which include atherosclerosis, multiple sclerosis, Alzheimer’s disease, asthma, and primary biliary cirrhosis. This review summarizes the Chlamydia infection associated diseases at the secondary sites of infection, and describes the potential mechanisms involved in the disease migration and pathogenesis.Keywords
Funding Information
- Institut Mérieux (IF039-2017, RK014-2018)
This publication has 124 references indexed in Scilit:
- Chlamydia pneumoniae-Specific IgE Is Prevalent in Asthma and Is Associated with Disease SeverityPLOS ONE, 2012
- Disulfide Bonding within Components of the Chlamydia Type III Secretion Apparatus Correlates with DevelopmentJournal of Bacteriology, 2011
- Hypoxia abrogates antichlamydial properties of IFN-γ in human fallopian tube cells in vitro and ex vivoProceedings of the National Academy of Sciences, 2010
- Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brainBMC Neuroscience, 2010
- Combination antibiotics as a treatment for chronic Chlamydia‐induced reactive arthritis: A double‐blind, placebo‐controlled, prospective trialArthritis & Rheumatism, 2010
- Treating reactive arthritis: insights for the clinicianTherapeutic Advances in Musculoskeletal Disease, 2009
- Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS)Journal of Neuroimmunology, 2009
- Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generationJournal of Neuroinflammation, 2008
- Mechanisms of host cell exit by the intracellular bacteriumChlamydiaProceedings of the National Academy of Sciences, 2007
- Detection of amyloid beta aggregates in the brain of BALB/c mice after Chlamydia pneumoniae infectionActa Neuropathologica, 2007